Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT01205893

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01205893
Other papers using this trial's data
  • A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina Heart (British Cardiac Society), 2021-01 DOI, PubMed 32719097, PMC8641517 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Efficacy of a device to narrow the coronary sinus in refractory angina The New England journal of medicine, 2015-02-05 DOI, PubMed 25651246, PMC6647842 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Canada, Denmark, Netherlands, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01205893. Randomized; double masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2013-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
Acronym
COSIRA
Condition
Refractory Angina
Intervention (Device)
Neovasc Reducer
Intervention (Device)
Control
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01205893
Content hash
bcb102d73ae70776dee6f80926dbbafb408c82fab9655216dcd6e2dbc077eb0e